Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Omeprazole Dosing in GERD
NCT02623816Phase 4Completed
- Sponsor
- MetroHealth Medical Center
- Start
- Aug 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by MetroHealth Medical Center. Started Aug 2014; status: completed.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02623816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02623816.